AVALYN PHARMA INC. (AVLN)

(30% Negative) AVALYN PHARMA INC. (AVLN) Announces Delay in investigator Trials for lung function Due to Patient Enrollment Issues, Manufacturing Considerations, Safety Review, Efficacy Assessment